BEI
PACB icon

Benjamin Edwards Inc’s Pacific Biosciences PACB Stock Holding History

Benjamin Edwards Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Sell
107,715
-7,834
-7% -$11.4K ﹤0.01% 1386
2026
Q1 		$152K Sell
115,549
-6,377
-5% -$11.4K ﹤0.01% 1326
2025
Q4 		$228K Sell
121,926
-11,951
-9% -$23K ﹤0.01% 1217
2025
Q3 		$171K Sell
133,877
-20,230
-13% -$27.4K ﹤0.01% 1255
2025
Q2 		$191K Sell
154,107
-5,695
-4% -$6.58K ﹤0.01% 1120
2025
Q1 		$189K Sell
159,802
-5,629
-3% -$8.63K ﹤0.01% 1054
2024
Q4 		$303K Buy
165,431
+41,884
+34% +$81.8K ﹤0.01% 969
2024
Q3 		$210K Buy
123,547
+122,554
+12,342% +$201K ﹤0.01% 1050
2024
Q2 		$1K Sell
993
-581
-37% -$1.17K ﹤0.01% 694
2024
Q1 		$6K Buy
1,574
+563
+56% +$3.3K ﹤0.01% 668
2023
Q4 		$10K Sell
1,011
-368
-27% -$3.01K ﹤0.01% 585
2023
Q3 		$12K Buy
1,379
+253
+22% +$2.89K ﹤0.01% 566
2023
Q2 		$15K Buy
1,126
+66
+6% +$802 ﹤0.01% 547
2023
Q1 		$12K Buy
1,060
+132
+14% +$1.31K ﹤0.01% 565
2022
Q4 		$8K Buy
928
+188
+25% +$1.62K ﹤0.01% 604
2022
Q3 		$4K Sell
740
-17
-2% -$98 ﹤0.01% 627
2022
Q2 		$3K Sell
757
-5
-0.7% -$30 ﹤0.01% 649
2022
Q1 		$7K Buy
762
+14
+2% +$161 ﹤0.01% 635
2021
Q4 		$15K Buy
+748
New +$18.1K ﹤0.01% 546

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Benjamin Edwards Inc's PACB Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Pacific Biosciences (PACB) stake by 6.8% in Q2 2026, selling an estimated $11.4K and leaving 107,715 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Benjamin Edwards Inc first reported a position in PACB in Q4 2021 and has held it in 19 quarters since. The position peaked at $303K in Q4 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Benjamin Edwards Inc held 107,715 shares of Pacific Biosciences worth $181K as of Q2 2026.
  • Benjamin Edwards Inc sold 7,834 Pacific Biosciences shares in Q2 2026, an estimated $11.4K.
  • Pacific Biosciences made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1386 holding.
  • Benjamin Edwards Inc first reported a position in Pacific Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Benjamin Edwards Inc's Pacific Biosciences position peaked at $303K in Q4 2024.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.